Home > Insider Trading > Filing (0001209191-20-025112)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1736295	E Maria Pasquale	1801 Augustine Cut-Off Wilmington DE 19803	Evp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-16	9,488	$68.62	32,837	No	4	M	Direct
Common Stock	Disposition	2020-04-16	9,488	$95.00	22,899	No	4	S	Direct
Common Stock	Acquisiton	2020-04-17	9,488	$72.27	32,837	No	4	M	Direct
Common Stock	Disposition	2020-04-17	9,488	$100.00	22,899	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non Qualified Stock Option (right to buy)	Disposition	2020-04-16	9,488	$0.00	9,488	$68.62
Common Stock	Non Qualified Stock Option (right to buy)	Disposition	2020-04-17	9,488	$0.00	9,488	$72.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,284		2028-07-01	No	4	M	Direct
13,284		2029-01-03	No	4	M	Direct

Footnotes

Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $95.00 - $95.01.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
This includes an aggregate of 20,648 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.